These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 12684647

  • 1. Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system.
    Zhu J, Okumura H, Ohtake S, Nakamura S, Nakao S.
    Oncol Rep; 2003; 10(3):705-9. PubMed ID: 12684647
    [Abstract] [Full Text] [Related]

  • 2. The molecular mechanism of arsenic trioxide-induced apoptosis and oncosis in leukemia/lymphoma cell lines.
    Zhu J, Okumura H, Ohtake S, Nakamura S, Nakao S.
    Acta Haematol; 2003; 110(1):1-10. PubMed ID: 12975549
    [Abstract] [Full Text] [Related]

  • 3. Arsenic trioxide induces regulated, death receptor-independent cell death through a Bcl-2-controlled pathway.
    Scholz C, Richter A, Lehmann M, Schulze-Osthoff K, Dörken B, Daniel PT.
    Oncogene; 2005 Oct 27; 24(47):7031-42. PubMed ID: 16007134
    [Abstract] [Full Text] [Related]

  • 4. Arsenic trioxide mediates intrinsic and extrinsic pathways of apoptosis and cell cycle arrest in acute megakaryocytic leukemia.
    Lam HK, Li K, Chik KW, Yang M, Liu VC, Li CK, Fok TF, Ng PC, Shing MM, Chuen CK, Yuen PM.
    Int J Oncol; 2005 Aug 27; 27(2):537-45. PubMed ID: 16010437
    [Abstract] [Full Text] [Related]

  • 5. Arsenic trioxide-induced apoptosis is independent of CD95 in lymphatic cell lines.
    Rojewski MT, Körper S, Thiel E, Schrezenmeier H.
    Oncol Rep; 2004 Feb 27; 11(2):509-13. PubMed ID: 14719092
    [Abstract] [Full Text] [Related]

  • 6. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
    Tolomeo M, Dusonchet L, Meli M, Grimaudo S, D'Alessandro N, Papoff G, Ruberti G, Rausa L.
    Cell Death Differ; 1998 Sep 27; 5(9):735-42. PubMed ID: 10200532
    [Abstract] [Full Text] [Related]

  • 7. Arsenic trioxide-induced apoptosis of human malignant lymphoma cell lines and its mechanisms.
    Lu D, Bai XC, Gui L, Li M, Zheng WS, Han XQ, Luo SQ.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct 27; 23(10):997-1001. PubMed ID: 14559676
    [Abstract] [Full Text] [Related]

  • 8. Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3.
    Jia P, Chen G, Huang X, Cai X, Yang J, Wang L, Zhou Y, Shen Y, Zhou L, Yu Y, Chen S, Zhang X, Wang Z.
    Chin Med J (Engl); 2001 Jan 27; 114(1):19-24. PubMed ID: 11779429
    [Abstract] [Full Text] [Related]

  • 9. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
    Yan H, Peng ZG, Wu YL, Jiang Y, Yu Y, Huang Y, Zhu YS, Zhao Q, Chen GQ.
    Haematologica; 2005 Dec 27; 90(12):1607-16. PubMed ID: 16330433
    [Abstract] [Full Text] [Related]

  • 10. Potential role of caspase-3 and -9 in arsenic trioxide-mediated apoptosis in PCI-1 head and neck cancer cells.
    Seol JG, Park WH, Kim ES, Jung CW, Hyun JM, Lee YY, Kim BK.
    Int J Oncol; 2001 Feb 27; 18(2):249-55. PubMed ID: 11172589
    [Abstract] [Full Text] [Related]

  • 11. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis.
    Kitamura K, Minami Y, Yamamoto K, Akao Y, Kiyoi H, Saito H, Naoe T.
    Leukemia; 2000 Oct 27; 14(10):1743-50. PubMed ID: 11021749
    [Abstract] [Full Text] [Related]

  • 12. Arsenic trioxide triggers a regulated form of caspase-independent necrotic cell death via the mitochondrial death pathway.
    Scholz C, Wieder T, Stärck L, Essmann F, Schulze-Osthoff K, Dörken B, Daniel PT.
    Oncogene; 2005 Mar 10; 24(11):1904-13. PubMed ID: 15674346
    [Abstract] [Full Text] [Related]

  • 13. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
    Spierings DC, de Vries EG, Vellenga E, de Jong S.
    Cell Death Differ; 2003 Jul 10; 10(7):808-22. PubMed ID: 12815464
    [Abstract] [Full Text] [Related]

  • 14. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
    Giri U, Terry NH, Kala SV, Lieberman MW, Story MD.
    Cancer Chemother Pharmacol; 2005 Jun 10; 55(6):511-21. PubMed ID: 15761769
    [Abstract] [Full Text] [Related]

  • 15. Phosphoinositide 3-kinase/Akt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias.
    Tabellini G, Tazzari PL, Bortul R, Evangelisti C, Billi AM, Grafone T, Martinelli G, Baccarani M, Martelli AM.
    Br J Haematol; 2005 Sep 10; 130(5):716-25. PubMed ID: 16115127
    [Abstract] [Full Text] [Related]

  • 16. Significance of intracellular arsenic trioxide for therapeutic response in acute promyelocytic leukemia.
    Sahu GR, Jena RK.
    Am J Hematol; 2005 Feb 10; 78(2):113-6. PubMed ID: 15682419
    [Abstract] [Full Text] [Related]

  • 17. Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4.
    Bernardini S, Nuccetelli M, Noguera NI, Bellincampi L, Lunghi P, Bonati A, Mann K, Miller WH, Federici G, Lo Coco F.
    Ann Hematol; 2006 Oct 10; 85(10):681-7. PubMed ID: 16733740
    [Abstract] [Full Text] [Related]

  • 18. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells.
    Juang SH, Pan WY, Kuo CC, Liou JP, Hung YM, Chen LT, Hsieh HP, Chang JY.
    Biochem Pharmacol; 2004 Jul 15; 68(2):293-303. PubMed ID: 15194001
    [Abstract] [Full Text] [Related]

  • 19. Depolarisation of the plasma membrane in the arsenic trioxide (As2O3)-and anti-CD95-induced apoptosis in myeloid cells.
    Nolte F, Friedrich O, Rojewski M, Fink RH, Schrezenmeier H, Körper S.
    FEBS Lett; 2004 Dec 03; 578(1-2):85-9. PubMed ID: 15581621
    [Abstract] [Full Text] [Related]

  • 20. Effects of 1, 6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl]diamantane (DPD), a reactive oxygen species and apoptosis inducing agent, on human leukemia cells in vitro and in vivo.
    Chang YF, Chi CW, Chern YT, Wang JJ.
    Toxicol Appl Pharmacol; 2005 Jan 01; 202(1):1-12. PubMed ID: 15589971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.